Drug information provided by: Merative, Micromedex®
Epcoritamab-bysp injection is used to treat certain types of large B-cell lymphoma (including diffuse large B-cell lymphoma [DLBCL] and high grade B-cell lymphoma) that has come back or did not respond to previous treatment in patients who have received 2 or more other medicines that did not work well. Lymphoma is a type of cancer where the body makes abnormal white blood cells.
This medicine is to be given only by or under the direct supervision of your doctor.
This product is available in the following dosage forms:
Portions of this document last updated: Feb. 01, 2024
Copyright: © Merative US L.P. 1973, 2024. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.